Byung-Jin Kwak
Corporate Officer/Principal chez Korea Advanced Institute of Science & Technology
Postes actifs de Byung-Jin Kwak
Sociétés | Poste | Début | Fin |
---|---|---|---|
Korea Advanced Institute of Science & Technology | Corporate Officer/Principal | - | - |
Historique de carrière de Byung-Jin Kwak
Anciens postes connus de Byung-Jin Kwak
Sociétés | Poste | Début | Fin |
---|---|---|---|
SPHERE POWER INC. | Comptroller/Controller/Auditor | - | - |
KB No. 3 Special Purpose Acquistion Co.
KB No. 3 Special Purpose Acquistion Co. Financial ConglomeratesFinance KB No. 3 Special Purpose Acquisition Co. is engaged in the research and development of protein and stem cell medicines. It is also involved in developing cosmetic ingredients and formulations, producing and distributing cosmetics, the disposal of cells and developing medical equipment, researching viruses and developing and distributing medical and skin care devices. The Company was founded on June 25, 2014 and is headquartered at Seoul, South Korea. | Comptroller/Controller/Auditor | 17/09/2015 | - |
Formation de Byung-Jin Kwak
Purdue University | Doctorate Degree |
The University of Texas at Austin | Masters Business Admin |
Seoul National University | Undergraduate Degree |
Statistiques
Internationale
Corée du Sud | 5 |
Etats-Unis | 3 |
Opérationnelle
Comptroller/Controller/Auditor | 2 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Consumer Services | 5 |
Finance | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
SPHERE POWER INC. | Health Technology |
Entreprise privées | 1 |
---|---|
KB No. 3 Special Purpose Acquistion Co.
KB No. 3 Special Purpose Acquistion Co. Financial ConglomeratesFinance KB No. 3 Special Purpose Acquisition Co. is engaged in the research and development of protein and stem cell medicines. It is also involved in developing cosmetic ingredients and formulations, producing and distributing cosmetics, the disposal of cells and developing medical equipment, researching viruses and developing and distributing medical and skin care devices. The Company was founded on June 25, 2014 and is headquartered at Seoul, South Korea. | Finance |
- Bourse
- Insiders
- Byung-Jin Kwak
- Expérience